Strs Ohio Sells 11,700 Shares of Maximus, Inc. (NYSE:MMS)

Strs Ohio lessened its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 63.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,700 shares of the health services provider's stock after selling 11,700 shares during the quarter. Strs Ohio's holdings in Maximus were worth $561,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in MMS. DekaBank Deutsche Girozentrale lifted its position in shares of Maximus by 501.4% in the fourth quarter. DekaBank Deutsche Girozentrale now owns 42,100 shares of the health services provider's stock worth $3,511,000 after purchasing an additional 35,100 shares in the last quarter. DAVENPORT & Co LLC bought a new stake in shares of Maximus in the fourth quarter worth $1,157,000. Legato Capital Management LLC increased its holdings in Maximus by 134.1% during the fourth quarter. Legato Capital Management LLC now owns 23,521 shares of the health services provider's stock worth $1,972,000 after buying an additional 13,474 shares during the last quarter. Graham Capital Management L.P. acquired a new position in Maximus during the third quarter worth $2,709,000. Finally, SG Capital Management LLC acquired a new position in shares of Maximus in the third quarter valued at $5,951,000. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Stock Down 0.2 %

Shares of MMS traded down $0.20 during trading hours on Friday, reaching $80.43. The stock had a trading volume of 205,291 shares, compared to its average volume of 230,063. Maximus, Inc. has a 12 month low of $72.39 and a 12 month high of $89.69. The firm has a 50-day simple moving average of $82.46 and a 200 day simple moving average of $81.38. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $4.91 billion, a price-to-earnings ratio of 26.63 and a beta of 0.72.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.06. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The business's revenue was up 6.2% compared to the same quarter last year. During the same period last year, the firm posted $0.94 EPS. Equities research analysts predict that Maximus, Inc. will post 5.42 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.49%. Maximus's dividend payout ratio (DPR) is presently 39.74%.

Insider Activity

In related news, CFO David Mutryn sold 8,000 shares of the business's stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the sale, the chief financial officer now owns 5,124 shares in the company, valued at approximately $430,159.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.40% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on MMS. StockNews.com raised shares of Maximus from a "hold" rating to a "buy" rating in a research report on Thursday, February 8th. Raymond James downgraded shares of Maximus from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 3rd.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.